New and future drug development for gastroesophageal reflux disease.
about
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleSex and Gender Differences in Gastroesophageal Reflux DiseaseA randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis.Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic ProceduresEffects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteersInhibiting the proton pump: mechanisms, benefits, harms, and questionsRandomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis.The Proton Pump Inhibitor Non-Responder: A Clinical ConundrumNew therapies for non-cardiac chest pain.Refractory gastroesophageal reflux disease.The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease.Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013.Foods Inducing Typical Gastroesophageal Reflux Disease Symptoms in Korea.Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance.Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
P2860
Q26741015-79941A2C-13B7-4788-8294-E5A54DECB3F1Q28067901-E6363248-6304-489F-A05F-0B0B012AD3C3Q33656886-9FDA4114-82F9-428E-AEF6-F68A07373492Q33811372-36408A07-31BC-4D3B-BFA7-21933EDCB28AQ35771441-51369BA4-1A42-4B35-813D-2A90B794BA52Q36186170-BFE28419-31A5-44B3-9EBF-3FA56292C3C0Q36536693-E48BB945-2A6A-4D9E-B1D0-A533F0853D0FQ36752080-CB66B28D-D39E-49D7-A2E2-86B58A69E4CDQ38205377-3BD40548-90BC-44A8-8D69-3C00254EB096Q38255997-ED53BDFE-5098-4EDC-9E22-4EE944860CF3Q38880408-DDE92682-8897-4BC5-8CF7-C18D09BEFAABQ39148759-29E68B91-C65C-4D32-A52A-61134C9FAD27Q40809955-EFFD4CD5-7C39-4382-A70C-37A74516D2E5Q40969258-45BDF30C-E196-4EF1-B6AD-D1A41655487FQ52615573-983343C6-239A-4087-AFEC-389A2C382858Q52881408-5B9673AA-5739-4CEC-94AA-ABDEF78A8151Q55128019-111AEE19-63FA-4A16-92C3-21A296A8A1EDQ57819648-6BF92D76-79AC-4DCD-9073-1DB7C6CA0982
P2860
New and future drug development for gastroesophageal reflux disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New and future drug development for gastroesophageal reflux disease.
@en
type
label
New and future drug development for gastroesophageal reflux disease.
@en
prefLabel
New and future drug development for gastroesophageal reflux disease.
@en
P2860
P356
P1476
New and future drug development for gastroesophageal reflux disease.
@en
P2093
Carla Maradey-Romero
Ronnie Fass
P2860
P356
10.5056/JNM.2014.20.1.6
P577
2013-12-30T00:00:00Z